Pricing Log in Create free account

InMed Pharmaceuticals Inc. (INM) vs Universe Pharmaceuticals INC (UPC)

InMed Pharmaceuticals Inc. and Universe Pharmaceuticals INC are both Drug Manufacturers Specialty & Generic companies. InMed Pharmaceuticals Inc. and Universe Pharmaceuticals INC are of similar size ($7.3M and $7.0M). InMed Pharmaceuticals Inc. has the higher net margin (0.00% vs −6.42%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Universe Pharmaceuticals INC leads on 7 and InMed Pharmaceuticals Inc. on 4.

Valuation

Metric INM UPC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 15.78 n/m 2.08
P/B n/m n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m 8.52 12.22
EV/Sales 15.54 (0.24) 2.87
Earnings yield (23.08%) (105.04%) (15.94%)
Free cash flow yield (11.11%) 0.00% 0.00%

Profitability

Metric INM UPC Drug Manufacturers Specialty & Generic median
Gross margin 33.62% 49.77% 53.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (6.42%) (2.45%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (261.69%) 0.00% (0.80%)
Return on assets (185.40%) 0.00% (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INM UPC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (6.73%) — 5.22%
EPS growth (last fiscal year) 62.68% 98.71% 42.91%
Revenue growth, 5-year CAGR — (10.27%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INM UPC Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.17 0.04
Current ratio 0.50 4.05 2.41
Net debt to EBITDA 0.20 10.15 1.01

Dividend

Metric INM UPC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric INM UPC Drug Manufacturers Specialty & Generic median
Market cap 7.26m 7.04m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack